scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1016/S0952-7915(02)00408-9 |
P698 | PubMed publication ID | 12413528 |
P2093 | author name string | Juan J Lafaille | |
Maria A Curotto de Lafaille | |||
P2860 | cites work | Differentiation of regulatory T cells 1 is induced by CD2 costimulation | Q24291651 |
Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity | Q24302386 | ||
Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation | Q24676080 | ||
Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells | Q28203889 | ||
B cells and professional APCs recruit regulatory T cells via CCL4 | Q28204573 | ||
A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis | Q29619339 | ||
CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production | Q29619536 | ||
Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo | Q30080006 | ||
Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study | Q30307035 | ||
Regulatory T cells overexpress a subset of Th2 gene transcripts | Q31035510 | ||
What is the role of regulatory T cells in transplantation tolerance? | Q33745150 | ||
Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. | Q34032006 | ||
The role of different subsets of T regulatory cells in controlling autoimmunity | Q34096248 | ||
Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance | Q34111451 | ||
CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor | Q34116317 | ||
Transcriptional mechanisms underlying lymphocyte tolerance. | Q34135663 | ||
Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells | Q34374601 | ||
CD4(+) regulatory T cells | Q34418015 | ||
Regulatory T cells in spontaneous autoimmune encephalomyelitis | Q34448458 | ||
Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. | Q34509694 | ||
Identification of regulatory T cells in tolerated allografts | Q34524237 | ||
Interleukin 2 signaling is required for CD4(+) regulatory T cell function | Q34527240 | ||
Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis | Q34719541 | ||
T-cell subsets in autoimmunity | Q35604988 | ||
Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells | Q36369028 | ||
In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. | Q36370315 | ||
Hyper immunoglobulin E response in mice with monoclonal populations of B and T lymphocytes | Q36376403 | ||
Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis | Q36401257 | ||
CD4(+) T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice | Q36401263 | ||
Role of interleukin 10 in specific immunotherapy | Q37387064 | ||
Fingerprints of anergic T cells | Q38300517 | ||
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus | Q40581531 | ||
Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen | Q40701079 | ||
IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. | Q40811244 | ||
A model for developmentally acquired thymus-dependent tolerance to central and peripheral antigens | Q41326884 | ||
Anergic T cells as suppressor cells in vitro | Q41461549 | ||
CD4+ T-cell subsets in autoimmunity | Q41716697 | ||
Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. | Q41907086 | ||
Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells | Q41908906 | ||
Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state | Q42466421 | ||
Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells | Q42944333 | ||
Cutaneous inflammatory disorder in integrin alphaE (CD103)-deficient mice | Q43407182 | ||
CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells | Q43562885 | ||
To E or not to E? Can an IL-4-induced B cell choose between IgE and IgG4? | Q44918734 | ||
Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans | Q45221904 | ||
A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood | Q46284741 | ||
Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency | Q47992795 | ||
Myelin protein expression in lymphoid tissues: implications for peripheral tolerance | Q48363174 | ||
CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations. | Q52165458 | ||
Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance | Q56904417 | ||
Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation | Q56904469 | ||
The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells | Q56904544 | ||
High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice | Q71641038 | ||
Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: a role of CD40 in regulatory T cell development | Q73311881 | ||
CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10 | Q73509865 | ||
Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide | Q73688337 | ||
Repertoire requirements of CD4+ T cells that prevent spontaneous autoimmune encephalomyelitis | Q73756000 | ||
Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms | Q73955062 | ||
Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell | Q74198800 | ||
Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen | Q74286698 | ||
Origin of regulatory T cells with known specificity for antigen | Q74381747 | ||
Damage control, rather than unresponsiveness, effected by protective DX5+ T cells in autoimmune diabetes | Q77192908 | ||
Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo | Q77342616 | ||
Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals | Q77704341 | ||
Control of immune pathology by regulatory T cells | Q77892048 | ||
CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice | Q78022304 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 771-778 | |
P577 | publication date | 2002-12-01 | |
P1433 | published in | Current Opinion in Immunology | Q15752917 |
P1476 | title | CD4(+) regulatory T cells in autoimmunity and allergy | |
P478 | volume | 14 |
Q33829731 | A reduction of recipient regulatory T cells by cyclophosphamide contributes to an anti-tumor effect of nonmyeloablative allogeneic stem cell transplantation in mice |
Q79780010 | Allergic sensitization and microbial load--a comparison between Finland and Russian Karelia |
Q49924076 | An ex vivo ruminal ovine model to study the immediate immune response in the context of bacterial lipopolysaccharide |
Q35936478 | An integrated view of suppressor T cell subsets in immunoregulation |
Q28071408 | Atopy and autoimmune thyroid diseases: melatonin can be useful? |
Q46057094 | Augmentation of regulatory T cells in allergic individuals by recombinant Der f 2 peptide with fungal immunomodulatory peptide fve. |
Q80622205 | Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells |
Q29618394 | CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells |
Q83160035 | CD25+ T(reg) specifically suppress auto-Ab generation against pancreatic tissue autoantigens |
Q36849492 | CD28-B7 interaction modulates short- and long-lived plasma cell function. |
Q36223583 | CD4+CD25+-regulatory T cells from mouse to man. |
Q36605447 | Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity |
Q46155473 | Characteristics of TCR/CD3 complex CD3{varepsilon} chains of regulatory CD4+ T (Treg) lymphocytes: role in Treg differentiation in vitro and impact on Treg in vivo. |
Q36150414 | Clinical application of human CD4+ CD25+ regulatory T cells for the treatment of inflammatory bowel diseases |
Q34133590 | Control of homeostatic proliferation by regulatory T cells |
Q33992511 | Cow's milk allergy: a complex disorder |
Q37260860 | Cumulative environmental changes, skewed antigen exposure, and the increase of allergy |
Q51052689 | Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. |
Q43977388 | Decreased FoxP3 gene expression in the nasal secretions from patients with allergic rhinitis |
Q53561906 | Demonstration of low-regulatory CD25High+CD4+ and high-pro-inflammatory CD28-CD4+ T-Cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption apheresis. |
Q80466965 | Downregulation of CD4+CD25+ regulatory T cells may underlie enhanced Th1 immunity caused by immunization with activated autologous T cells |
Q57173908 | Effect of Mycobacterium vaccae on atopic dermatitis in children of different ages |
Q36676017 | Effect of bacillus Calmette-Guérin vaccination on CD4+Foxp3+ T cells during acquired immune response to Mycobacterium tuberculosis infection |
Q51744632 | Effect of desensitization in solid organ transplant recipients depends on some cytokines genes polymorphism. |
Q58196727 | Evaluation of Natural Regulatory T Cells in Subjects with Selective IgA Deficiency: From Senior Idea to Novel Opportunities |
Q49427525 | Exon 3 mutations of CTNNB1 drive tumorigenesis: a review |
Q42276749 | Expression analysis of Foxp3 in T cells from bovine leukemia virus infected cattle |
Q54236063 | Expression of Ets-1 and FOXP3 mRNA in CD4(+)CD25 (+) T regulatory cells from patients with systemic lupus erythematosus. |
Q35829151 | Full restoration of peripheral Foxp3+ regulatory T cell pool by radioresistant host cells in scurfy bone marrow chimeras |
Q35742927 | Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis. |
Q33867263 | Gut Microbiota Co-microevolution with Selection for Host Humoral Immunity |
Q24802813 | HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells |
Q42969634 | High proportions of FOXP3(+) CD25(high) T cells in neonates are positively associated with allergic sensitization later in childhood |
Q62801176 | Human IL-19 regulates immunity through auto-induction of IL-19 and production of IL-10 |
Q35211699 | Hypothesis: dysregulation of immunologic balance resulting from hygiene and socioeconomic factors may influence the epidemiology and cause of glomerulonephritis worldwide |
Q40164065 | IFN-gamma mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy |
Q36403560 | IL-18-induced CD83+CCR7+ NK helper cells |
Q64903098 | Immune reaction by cytoreductive prostatectomy. |
Q35083879 | Immune regulatory mechanisms influence early pathology in spinal cord injury and in spontaneous autoimmune encephalomyelitis |
Q84923108 | Impaired function of regulatory T cells in cord blood of children of allergic mothers |
Q36399048 | In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes |
Q33471458 | Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression |
Q35835456 | Inhibition of experimental asthma by indoleamine 2,3-dioxygenase |
Q35849633 | Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma |
Q35568027 | Keeping hopes high |
Q35810098 | LYRA, a webserver for lymphocyte receptor structural modeling |
Q48858723 | Lack of association between TESPA1 gene polymorphisms (rs1801876, rs2171497, rs4758994, and rs997173) and ankylosing spondylitis in a Chinese population |
Q34103249 | Malignant B cells induce the conversion of CD4+CD25- T cells to regulatory T cells in B-cell non-Hodgkin lymphoma |
Q36263707 | Markers to measure immunomodulation in human nutrition intervention studies. |
Q28272127 | Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda1/IL-29) |
Q33617780 | Modulatory role of regulatory T cells in a murine model of severe equine asthma |
Q36541003 | New aspects on inflammation in allergic diseases. |
Q34477650 | OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity |
Q33840440 | Oral tolerance in the absence of naturally occurring Tregs |
Q44890967 | Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study |
Q38502556 | Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis |
Q46401511 | Putative regulatory T cells are impaired in cord blood from neonates with hereditary allergy risk |
Q45859587 | Reduced function of CD4+25+ regulatory T cell fraction in silicosis patients |
Q42667085 | Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression |
Q35582278 | Regulatory T cells accumulate in the lung allergic inflammation and efficiently suppress T-cell proliferation but not Th2 cytokine production |
Q36079905 | Regulatory T cells and autoimmune disease |
Q36419022 | Regulatory T cells in lupus |
Q33236315 | Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo |
Q45877596 | Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta? |
Q35628016 | Role of T cell co-stimulation in murine models of allergic asthma |
Q36580331 | Specialized role of migratory dendritic cells in peripheral tolerance induction |
Q45914983 | Suppression of Th1- and Th2-type immune responses in infant mouse spleen after prenatal and postnatal exposure to low-level toluene and peptidoglycan. |
Q37084875 | T-cell activation through immunological synapses and kinapses |
Q92277085 | The Pungent and Hot Chinese Herbs Cause Heat Syndrome in Rats by Affecting the Regulatory T Cells |
Q24816497 | The allergy adjuvant effect of particles - genetic factors influence antibody and cytokine responses |
Q36218421 | The development and function of memory regulatory T cells after acute viral infections |
Q34922215 | The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation |
Q51765029 | The expression profile of functional regulatory T cells, CD4+CD25high+/forkhead box protein P3+, in patients with ulcerative colitis during active and quiescent disease. |
Q36232960 | The immunopathogenesis of cow's milk protein allergy (CMPA). |
Q37037449 | The role of CD4+CD25+ T regulatory cells in autoimmune diseases |
Q36752196 | The role of natural regulatory T cells in infection |
Q35685189 | The role of regulatory T cells in allergy |
Q37409192 | Therapeutic efficacy of soluble receptor activator of nuclear factor-kappa B-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma |
Q79274214 | Timing of IFN-β Exposure during Human Dendritic Cell Maturation and Naive Th Cell Stimulation Has Contrasting Effects on Th1 Subset Generation: A Role for IFN-β-Mediated Regulation of IL-12 Family Cytokines and IL-18 in Naive Th Cell Differentiation |
Q36942513 | Tolerance and autoimmunity: lessons at the bedside of primary immunodeficiencies |
Q37420965 | Transforming Growth Factor-β Signaling Guides the Differentiation of Innate Lymphoid Cells in Salivary Glands |
Q36466223 | Translating the concept of suppressor/regulatory T cells to clinical applications |
Q41519827 | Treg/Th17 cell balance and phytohaemagglutinin activation of T lymphocytes in peripheral blood of systemic sclerosis patients |
Q36381918 | Tumor-infiltrating T lymphocytes: friends or foes? |
Q45871925 | Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy |
Q38888149 | Understanding the Regulatory Roles of Natural Killer T Cells in Rheumatoid Arthritis: T Helper Cell Differentiation Dependent or Independent? |
Q36107768 | Unraveling innate immunity using large scale N-ethyl-N-nitrosourea mutagenesis |
Q30498716 | Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice |
Q28282226 | World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines |